High DRP1 expression in tumor tissues was not only correlated with HCC biological aggressiveness (large tumor size, poor differentiation and late stage) (Table S1), but also associated with poor prognosis of patients (shorter OS and higher recurrence) (Fig. 5f, g). Here, DNM1L is linked to hepatocellular carcinoma.